| PERIOD ENDING | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | 31-Oct-08 | | Total Revenue | 134,086 | 130,166 | 130,437 | 156,716 | | Cost of Revenue | 88,275 | 87,648 | 86,533 | 99,257 | | | Gross Profit | 45,811 | 42,518 | 43,904 | 57,459 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 24,389 | 21,199 | 22,451 | 28,749 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 21,422 | 21,319 | 21,453 | 28,710 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 184 | 49 | (47) | (419) | | Earnings Before Interest And Taxes | 21,606 | 21,368 | 21,406 | 28,291 | | Interest Expense | 177 | 112 | 195 | 363 | | Income Before Tax | 21,429 | 21,256 | 21,211 | 27,928 | | Income Tax Expense | 6,511 | 6,960 | 5,860 | 9,410 | | Minority Interest | (3,786) | (3,755) | (4,034) | (4,868) | | | | Net Income From Continuing Ops | 11,132 | 10,541 | 11,317 | 13,650 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 11,132 | 10,541 | 11,317 | 13,650 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $11,132 | $10,541 | $11,317 | $13,650 |
|
1.23% Nasdaq 
Income Statement
